Interim results and dividend declaration
AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT ISIN: ZAE000078416
Summarised unaudited interim results for the six months ended 31 December 2020 and dividend
Introduction to the AfroCentric Group
AfroCentric is a Level 1 black-owned JSE listed investment holding company, which owns and operates a
diverse range of healthcare related enterprises, which include, specialised medical scheme administration
and management, the supply of pharmaceuticals, including a range of healthcare products and services,
to both the public and private healthcare sectors. A principal objective of the group, is to ensure the delivery
of efficient health management services and the distribution of quality products, all at manageable and
affordable cost, for the benefit of scheme clients, scheme members and the group’s growing customer
base. AfroCentric has been able to successfully broaden its interests in the industry, by continuing to
pursue new opportunities, to expand and rationalise its presence in the healthcare sector.
The Board is pleased to present a summary of the Company’s results for the six months ended
31 December 2020.
% Unaudited six Unaudited six
change months ended months ended
31 December 31 December
Total revenue 25.3 3 898.2 million 3 111.3 million
Operating profit 16.5 511.8 million 439.3 million
Operating profit (excluding lease reversals) 17.9 469.1 million 398.0 million
Healthcare Services Operating profit 16.4 313.5 million 269.4 million
Healthcare Retail Operating profit 20.9 155.6 million 128.7 million
Profit before tax 19.1 320.1 million 268.7 million
Profit after tax 13.0 226.5 million 200.5 million
Basic earnings (rands) 8.3 146.0 million 134.8 million
Headline earnings (rands) 10.9 149.5 million 134.7 million
Basic earnings (cents per share) 8.3 25.43 23.48
Headline earnings (cents per share) 10.9 26.03 23.47
Weighted average number of ordinary shares 574.3 million 574.2 million
The Board has pleasure in announcing that an interim gross dividend per ordinary share of 17 cents has
been declared for the six months ended 31 December 2020. Dividends are subject to Dividends
Withholding Tax. The payment date for the dividend is Monday, 17 May 2021.
• Dividends have been declared out of profits available for distribution.
• South African Dividends Withholding Tax rate is 20%.
• The gross dividend amount is 17 cents per ordinary share.
• The net cash dividend amount is therefore 13.60000 cents per ordinary share.
• The Company has 574 951 251 ordinary shares in issue as at the declaration date.
• The Company’s income tax reference number is 9600/148/71/3.
The salient dates relating to the dividend are as follows:
Last day to trade cum dividend Tuesday, 11 May 2021
Shares commence trading ex-dividend Wednesday, 12 May 2021
Dividend record date Friday, 14 May 2021
Dividend payment date Monday, 17 May 2021
Share certificates for ordinary shares may not be dematerialised or rematerialized between Wednesday,
12 May 2021 and Friday, 14 May 2021, both days inclusive.
This short-form announcement is the responsibility of the Directors of the Company and is a summary of the
information in the full announcement which is available for viewing on the following websites:
Company’s website: http://www.afrocentric.za.com/inv-reporting.php.
JSE website: https://senspdf.jse.co.za/documents/2021/jse/isse/act/act2021.pdf
Any investment decision by investors and/or shareholders should be based on consideration of the full
announcement, copies of which are also available for inspection at our offices on work-days during business
hours, at no charge:
On behalf of the Board
Dr ATM Mokgokong Mr A Banderker
Chairperson Group Chief Executive Officer
9 March 2021
Sponsor: Sasfin Capital (a member of Sasfin Group)
Date: 09-03-2021 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.